Lantheus Biosciences Ltd. clinical trials
Acquired by Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
The registry lists 4 studies whose lead sponsor is Lantheus Biosciences Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Before and after it joined Lantheus Holdings, Inc.
- First submitted before Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.
- 4
- First submitted after Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Lantheus Biosciences Ltd.4 studies
Something wrong with this grouping? Tell us on the Lantheus Holdings, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Lantheus Holdings, Inc. studies →
- [18F]PI-2620 Phase 3 Histopathological StudyRecruitingNCT05641688Phase 3
Sponsor listed in the registry: Lantheus Biosciences Ltd. · First submitted before Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.
- Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With ADCompletedNCT02681172Phase 4
Sponsor listed in the registry: Lantheus Biosciences Ltd. · First submitted before Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.
- Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) PatientsCompletedNCT01138111Phase 1
Sponsor listed in the registry: Lantheus Biosciences Ltd. · First submitted before Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.
- PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy VolunteersCompletedNCT01287845Phase 1
Sponsor listed in the registry: Lantheus Biosciences Ltd. · First submitted before Lantheus Biosciences Ltd. became part of Lantheus Holdings, Inc.